Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Degenhardt

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjectsJ Gordon Still, Kay Clark, Thorsten P Degenhardt, et al.
Klinische Padiatrie|September 30, 2004
[The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics]T Reindl, P Degenhardt, W Luck, et al.
The Biochemical Journal|June 1, 1997
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteinsM U Ahmed, E Brinkmann Frye, T P Degenhardt, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
N-methylpyridoxamine: novel canine vitamin B6 urine metaboliteKaren L Ericson, Vincent M Maloney, J Dennis Mahuren, et al.
Kidney International|November 5, 1997
Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremiaT P Degenhardt, L Grass, S Reddy, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjectsJ Gordon Still, Jennifer Schranz, Thorsten P Degenhardt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2020
A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal CandidiasisStephen R Brand, Jack D Sobel, Paul Nyirjesy, et al.
American Journal of Obstetrics and Gynecology|March 15, 2018
A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasisStephen R Brand, Thorsten P Degenhardt, Karen Person, et al.
American Journal of Nephrology|September 8, 2007
Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathyMark E Williams, W Kline Bolton, Raja G Khalifah, et al.
The European Respiratory Journal|October 3, 2009
The effect of surgery on lung volume and conventional monitoring parameters in ventilated newborn infantsH Proquitté, O Freiberger, S Yilmaz, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjectsJ Gordon Still, Kay Clark, Thorsten P Degenhardt, et al.
Klinische Padiatrie|September 30, 2004
[The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics]T Reindl, P Degenhardt, W Luck, et al.
The Biochemical Journal|June 1, 1997
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteinsM U Ahmed, E Brinkmann Frye, T P Degenhardt, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
N-methylpyridoxamine: novel canine vitamin B6 urine metaboliteKaren L Ericson, Vincent M Maloney, J Dennis Mahuren, et al.
Kidney International|November 5, 1997
Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremiaT P Degenhardt, L Grass, S Reddy, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjectsJ Gordon Still, Jennifer Schranz, Thorsten P Degenhardt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2020
A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal CandidiasisStephen R Brand, Jack D Sobel, Paul Nyirjesy, et al.
American Journal of Obstetrics and Gynecology|March 15, 2018
A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasisStephen R Brand, Thorsten P Degenhardt, Karen Person, et al.
American Journal of Nephrology|September 8, 2007
Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathyMark E Williams, W Kline Bolton, Raja G Khalifah, et al.
The European Respiratory Journal|October 3, 2009
The effect of surgery on lung volume and conventional monitoring parameters in ventilated newborn infantsH Proquitté, O Freiberger, S Yilmaz, et al.
Pageof 3